We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$356B
AUM Growth
+$14.1B
Cap. Flow
-$4.79B
Cap. Flow %
-1.35%
Top 10 Hldgs %
30.2%
Holding
3,385
New
54
Increased
1,101
Reduced
1,417
Closed
52

Top Buys

Rank Stock Value
1
SW
Smurfit Westrock
SW
+$622M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$269M
3
EMR icon
Emerson Electric
EMR
+$268M
4
NOW icon
ServiceNow
NOW
+$252M
5
ADI icon
Analog Devices
ADI
+$235M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$542M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$499M
3
MNST icon
Monster Beverage
MNST
+$326M
4
NVDA icon
NVIDIA
NVDA
+$316M
5
MCD icon
McDonald's
MCD
+$302M

Sector Composition

Rank Sector Weight
1 Technology 30.77%
2 Financials 12.09%
3 Healthcare 11.08%
4 Consumer Discretionary 10.82%
5 Industrials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMPX icon
3276
Amprius Technologies
AMPX
$1.6B
$87.9K ﹤0.01%
79,154
+66,083
+506% +$72.8K
LVO icon
3277
LiveOne
LVO
$57.6M
$85.1K ﹤0.01%
8,969
– –
JBIO
3278
Jade Biosciences
JBIO
$1.34B
$83.7K ﹤0.01%
1,144
– –
OIA icon
3279
Invesco Municipal Income Opportunities Trust
OIA
$291M
$82.8K ﹤0.01%
+12,065
New +$78.5K
LNSR icon
3280
LENSAR
LNSR
$70.1M
$81.8K ﹤0.01%
17,865
– –
GALT icon
3281
Galectin Therapeutics
GALT
$218M
$76K ﹤0.01%
27,623
– –
CBUS icon
3282
Cibus
CBUS
$137M
$66K ﹤0.01%
20,234
– –
SKIN icon
3283
SkinHealth Systems
SKIN
$87.6M
$63K ﹤0.01%
43,730
– –
DTI icon
3284
Drilling Tools International
DTI
$79.8M
$62.8K ﹤0.01%
16,830
– –
MRDN
3285
Meridian Holdings Inc
MRDN
$182M
$61.8K ﹤0.01%
2,210
– –
SST icon
3286
System1
SST
$17.3M
$56.4K ﹤0.01%
5,033
– –
OPAD icon
3287
Offerpad Solutions
OPAD
$24.6M
$56.3K ﹤0.01%
1,387
– –
SLND icon
3288
Southland Holdings
SLND
$34.8M
$48.5K ﹤0.01%
13,098
– –
PRLD icon
3289
Prelude Therapeutics
PRLD
$370M
$34.8K ﹤0.01%
16,797
– –
VCSA
3290
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$34.6K ﹤0.01%
+12,308
New +$45.3K
LNAI
3291
Lunai Bioworks
LNAI
$11.6M
$32K ﹤0.01%
829
– –
MKTW icon
3292
MarketWise
MKTW
$54M
$28.6K ﹤0.01%
2,138
– –
STEM icon
3293
Stem
STEM
$52.9M
$11.6K ﹤0.01%
1,662
-22,038
-93% -$347K
ADVWW
3294
DELISTED
Advantage Solutions Warrant
ADVWW
$3.5K ﹤0.01%
10,558
– –
ACWI icon
3295
iShares MSCI ACWI ETF
ACWI
$33.5B
– –
-1,014,677
Closed -$114M
AGEN
3296
Agenus
AGEN
$304M
– –
-61,655
Closed -$1.03M
ANGI icon
3297
Angi Inc
ANGI
$207M
– –
-5,000
Closed -$96K
BSV icon
3298
Vanguard Short-Term Bond ETF
BSV
$44.6B
– –
-320,431
Closed -$24.6M
DADA
3299
DELISTED
Dada Nexus
DADA
– –
-38,800
Closed -$48.9K
DNA icon
3300
Ginkgo Bioworks
DNA
$505M
– –
-670
Closed -$8.96K
130 131
132
133 134

Similar funds

Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Nuveen's Q3 2024 Portfolio in Review

As of Q3 2024, Nuveen held 3,385 positions worth $356B, up 4.1% from $342B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 3.1%. Nuveen opened 54 new positions and exited 52, leaving the 3,385-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q3 2024 buy was Smurfit Westrock: 13,669,531 shares worth $676M.
  • Nuveen added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2024, an estimated $269M increase.
  • Nuveen's biggest Q3 2024 reduction was Microsoft, cutting an estimated $542M.
  • Nuveen fully exited iShares MSCI ACWI ETF in Q3 2024, selling an estimated $114M.
  • Nuveen's ten largest holdings make up 30% of its $356B portfolio in Q3 2024.
  • Nuveen opened 54 new positions and closed 52 in Q3 2024.
  • Nuveen's portfolio value rose 4.1% quarter-over-quarter to $356B.

Based on Nuveen's 13F filing for Q3 2024, filed 14 Nov 2024.